Orange Book product · Brand (NDA)
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
At a glance
Jul 30, 2020
Approved
Brand (NDA)
Application
AP
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 30, 2020
6 yr ago
Today
Patent 10993952 expires
Listed drug product patent expiration.
Feb 15, 2036
in 9 yr 10 mo
Patent 12329767 expires
Listed drug product patent expiration.
Feb 15, 2036
in 9 yr 10 mo
Pharmaceutical detail
Active ingredient
CYCLOPHOSPHAMIDE
Strength
1GM/5ML (200MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
NDA 212501
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023CYCLOPHOSPHAMIDEBrand (NDA)
NDA 217150 · SANDOZ
- 2023CYCLOPHOSPHAMIDEBrand (NDA)
NDA 217651 · BAXTER HLTHCARE CORP
- 2023FRINDOVYXBrand (NDA)
NDA 210852 · AVYXA HOLDINGS
- 2021CYCLOPHOSPHAMIDEBrand (NDA)
NDA 210735 · EUGIA PHARMA SPECLTS
- 2013CYCLOPHOSPHAMIDEBrand (NDA)
NDA 203856 · HIKMA
- —CYTOXANBrand (NDA)
NDA 012142 · BAXTER HLTHCARE
- —CYTOXANBrand (NDA)
NDA 012141 · BAXTER HLTHCARE
- 2024CYCLOPHOSPHAMIDEGeneric (ANDA)
ANDA 218632 · HAINAN POLY
- 2024CYCLOPHOSPHAMIDEGeneric (ANDA)
ANDA 218644 · EPIC PHARMA LLC
- 2024CYCLOPHOSPHAMIDEGeneric (ANDA)
ANDA 218282 · EIRGEN
- 2024CYCLOPHOSPHAMIDEGeneric (ANDA)
ANDA 216783 · NEXUS
- 2023CYCLOPHOSPHAMIDEGeneric (ANDA)
ANDA 216958 · HIKMA
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10993952 | Feb 15, 2036 | in 9 yr 10 mo | Product |
| 12329767 | Feb 15, 2036 | in 9 yr 10 mo | Product |

